Epitope Spreading in Immune Checkpoint Inhibitor-Associated Bullous Pemphigoid

Affiliations

¹ Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan.
² Kurume University Institute of Cutaneous Cell Biology, Fukuoka, Japan.
³ Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan.

Hiroshi Koga et al. JAMA Dermatol. 2025.

. 2025 May 1;161(5):557-559.

doi: 10.1001/jamadermatol.2024.6665.

¹ Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan.
² Kurume University Institute of Cutaneous Cell Biology, Fukuoka, Japan.
³ Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan.

No abstract available

Plain language summary

This case report describes a patient with immune checkpoint inhibitor–associated bullous pemphigoid and preexisting anti-BP180–C-terminus antibodies.